A look back at the therapeutic role of music in psilocybin therapy.
The psychoactive effects of DMT were discovered in 1956 by Dr Szàra.
Psychedelics present unique epistemological and ethical challenges.
Recent antidepressant exposure may reduce the treatment efficacy of MDMA.
The link between oxytocin and MDMA is less straightforward than once thought.
Escalating LSD doses lead to more pronounced subjective and autonomic effects, while pre-administration of ketanserin prevents the effects of a high LSD dose.
Feasibility, safety, and potential efficacy of psilocybin-assisted group therapy was demonstrated in treating demoralization in this marginalized population.
A new clinical study reports that 20µg of LSD significantly reduces pain perception. This promising investigation builds on the little-known history of research into LSD as a potential analgesic.
The first trial will determine the sublingual dose equivalent to 25 mg psilocybin administered orally.
Researchers will examine whether MDMA can offset some of the negative side effects of LSD in a therapeutic setting.